Antleron

Ambachtenlaan 1
3001 Leuven
BE
Antleron
Foundation date
21/11/2014
Sector
#Biotechnology / R&D ServicesTherapeutic areas
- #Cardiovascular
- #Digestive system
- #Diseases of the blood and blood-forming organs - immune disorders
- #Injury - poisoning and certain other consequences of external causes
- #Musculoskeletal system and connective tissue
- #Skin and subcutaneous tissue
- #Symptoms - signs and abnormal clinical and laboratory findings - not elsewhere classified
We are Antleron, a nimble team that will revolutionise medicine by leading the development of next generation advanced therapies and medical devices. By merging the potential of cells, biomaterials, biologics, 3D printing and bioreactors we will accelerate the engineering of medicinal products, devices and processes that will change health care and result in a better life for all. The Antleron business philosophy is to create sustainable ventures through risk & reward sharing partnerships.
Upcoming events
All events-
2809 '22
NLSDays 2022
Event by: SwedenBIO -
2809 '22
Neurotechnologies
Event by: VIB -
0712 '22
Emerging Applications of Microbes (2nd edition)
Event by: VIB
Latest news
More news-
ANeuroTech receives positive feedback from the FDA for its pivotal Phase IIIb development programme for ANT-01 as an adjunctive anti-depression drug for Major Depressive Disorder
3 hours ago
Read more
-
Confo Therapeutics awarded EUR 1.7M VLAIO grant to expand application of ConfoBody® drug discovery and development technology in rare diseases
Tuesday June 28th 2022
Read more
-
MRM Health starts clinical trial with next-generation optimized consortium therapeutic MH002 in Pouchitis
Tuesday June 28th 2022
Read more
Jobs
More jobs-
05/07/22
Brussels
Postdoctoral position in cancer immunology and the tumor immune microenvironment
Permanent
VIB -
-